We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.18B
AUM Growth
-$113M
Cap. Flow
-$283M
Cap. Flow %
-12.95%
Top 10 Hldgs %
39.24%
Holding
318
New
18
Increased
122
Reduced
118
Closed
20
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCZ icon
226
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$353K 0.02%
4,831
-215
-4% -$16K
INTU icon
227
Intuit
INTU
$86.5B
$346K 0.02%
538
+47
+10% +$29K
BSX icon
228
Boston Scientific
BSX
$69.5B
$344K 0.02%
8,098
-2,352
-23% -$98.8K
AZO icon
229
AutoZone
AZO
$49.2B
$340K 0.02%
162
BND icon
230
Vanguard Total Bond Market
BND
$157B
$340K 0.02%
4,016
-19
-0.5% -$1.62K
TRV icon
231
Travelers Companies
TRV
$78.1B
$339K 0.02%
2,170
ADBE icon
232
Adobe
ADBE
$99.5B
$335K 0.02%
591
+24
+4% +$15K
GWX icon
233
State Street SPDR S&P International Small Cap ETF
GWX
$856M
$334K 0.02%
8,856
ON icon
234
ON Semiconductor
ON
$31.8B
$330K 0.02%
4,866
+229
+5% +$13K
HIPS icon
235
GraniteShares HIPS US High Income ETF
HIPS
$109M
$321K 0.01%
21,013
PPL
236
PPL Corp
PPL
$26.5B
$319K 0.01%
10,600
-57
-0.5% -$1.65K
VEU icon
237
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$314K 0.01%
5,125
-61
-1% -$3.77K
MU icon
238
Micron Technology
MU
$930B
$310K 0.01%
3,324
-964
-22% -$75.3K
MRNS
239
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$305K 0.01%
25,680
-3,448
-12% -$39.8K
SSO icon
240
ProShares Ultra S&P500
SSO
$7.87B
$301K 0.01%
8,232
IWR icon
241
iShares Russell Mid-Cap ETF
IWR
$56B
$295K 0.01%
3,552
-155
-4% -$12.7K
PKG icon
242
Packaging Corp of America
PKG
$21.9B
$292K 0.01%
2,143
-22
-1% -$2.96K
VXUS icon
243
Vanguard Total International Stock ETF
VXUS
$155B
$291K 0.01%
+4,573
New +$294K
FLG
244
Flagstar Bank National Association
FLG
$5.93B
$286K 0.01%
7,799
+1,346
+21% +$51.3K
AMT icon
245
American Tower
AMT
$80.8B
$285K 0.01%
976
-9
-0.9% -$2.46K
AZN icon
246
AstraZeneca
AZN
$263B
$285K 0.01%
2,450
-1
-0% -$118
VB icon
247
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$285K 0.01%
1,260
+186
+17% +$42.3K
EZU icon
248
iShare MSCI Eurozone ETF
EZU
$9.64B
$281K 0.01%
5,733
+70
+1% +$3.45K
ARKK icon
249
ARK Innovation ETF
ARKK
$5.64B
$280K 0.01%
2,965
-289
-9% -$31.6K
SPYV icon
250
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.1B
$277K 0.01%
6,601

Similar funds

Grimes & Company's Q4 2021 Portfolio in Review

As of Q4 2021, Grimes & Company held 318 positions worth $2.18B, down 4.9% from $2.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Grimes & Company withdrew a net $283M in Q4 2021, closing 20 positions and reducing 118 holdings. Its most notable exit was First Trust Preferred Securities and Income ETF, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Grimes & Company opened a new position in JPMorgan Ultra-Short Income ETF worth $2.58M.

  • Grimes & Company's largest Q4 2021 buy was JPMorgan Ultra-Short Income ETF: 51,110 shares worth $2.58M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q4 2021, an estimated $10.9M increase.
  • Grimes & Company's biggest Q4 2021 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $51.5M.
  • Grimes & Company fully exited First Trust Preferred Securities and Income ETF in Q4 2021, selling an estimated $122M.
  • Grimes & Company's ten largest holdings make up 39% of its $2.18B portfolio in Q4 2021.
  • Grimes & Company opened 18 new positions and closed 20 in Q4 2021.
  • Grimes & Company's portfolio value fell 4.9% quarter-over-quarter to $2.18B.

Based on Grimes & Company's 13F filing for Q4 2021, filed 1 Feb 2022.